Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mónica Furlano

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 14, 2019
New therapeutic options for Alport syndromeRoser Torra, Mónica Furlano
Clinical Kidney Journal|November 10, 2021
Autosomal dominant polycystic kidney disease: possibly the least silent cause of chronic kidney diseaseRoser Torra, Maria Vanessa Pérez-Gómez, Mónica Furlano
Clinical Kidney Journal|August 4, 2021
Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reportsRoser Torra, Mónica Furlano, Alberto Ortiz, et al.
Nefrologia|January 26, 2024
Correlation of X chromosome inactivation with clinical presentation of Fabry disease in a case reportPablo Rodríguez Doyágüez, Mónica Furlano, Elisabet Ars Criach, et al.
Patient Preference and Adherence|November 16, 2013
Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherenceM Jesús Lloret, César Ruiz-García, Iara Dasilva, et al.
BMC Nephrology|April 13, 2019
Novel homozygous OSGEP gene pathogenic variants in two unrelated patients with Galloway-Mowat syndrome: case report and review of the literatureAndrea Domingo-Gallego, Mónica Furlano, Marc Pybus, et al.
American Journal of Nephrology|October 23, 2018
Autosomal Dominant Polycystic Kidney Disease: Clinical Assessment of Rapid ProgressionMónica Furlano, Irene Loscos, Teresa Martí, et al.
Case Reports in Genetics|January 9, 2023
The Benefits of Early versus Late Therapeutic Intervention in Fabry DiseaseMónica Furlano, Elisabet Ars, Anna Matamala, et al.
Nefrologia|February 14, 2025
Indications for genetic testing in adults with focal segmental glomerulosclerosisMelissa Pilco-Terán, Amir Shabaka, Mónica Furlano, et al.
Clinical Kidney Journal|May 2, 2022
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney diseaseJavier Naranjo, Mónica Furlano, Ferran Torres, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 14, 2019
New therapeutic options for Alport syndromeRoser Torra, Mónica Furlano
Clinical Kidney Journal|November 10, 2021
Autosomal dominant polycystic kidney disease: possibly the least silent cause of chronic kidney diseaseRoser Torra, Maria Vanessa Pérez-Gómez, Mónica Furlano
Clinical Kidney Journal|August 4, 2021
Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reportsRoser Torra, Mónica Furlano, Alberto Ortiz, et al.
Nefrologia|January 26, 2024
Correlation of X chromosome inactivation with clinical presentation of Fabry disease in a case reportPablo Rodríguez Doyágüez, Mónica Furlano, Elisabet Ars Criach, et al.
Patient Preference and Adherence|November 16, 2013
Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherenceM Jesús Lloret, César Ruiz-García, Iara Dasilva, et al.
BMC Nephrology|April 13, 2019
Novel homozygous OSGEP gene pathogenic variants in two unrelated patients with Galloway-Mowat syndrome: case report and review of the literatureAndrea Domingo-Gallego, Mónica Furlano, Marc Pybus, et al.
American Journal of Nephrology|October 23, 2018
Autosomal Dominant Polycystic Kidney Disease: Clinical Assessment of Rapid ProgressionMónica Furlano, Irene Loscos, Teresa Martí, et al.
Case Reports in Genetics|January 9, 2023
The Benefits of Early versus Late Therapeutic Intervention in Fabry DiseaseMónica Furlano, Elisabet Ars, Anna Matamala, et al.
Nefrologia|February 14, 2025
Indications for genetic testing in adults with focal segmental glomerulosclerosisMelissa Pilco-Terán, Amir Shabaka, Mónica Furlano, et al.
Clinical Kidney Journal|May 2, 2022
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney diseaseJavier Naranjo, Mónica Furlano, Ferran Torres, et al.
Pageof 4